Listen now (56 min) | This week, the FDA decided to pause the Johnson & Johnson vaccine following reports that six women—of the nearly 7 million Americans who have received the J&J vaccine—developed serious blood clots after getting the jab. Is pausing the vaccine worth the tradeoffs? Will the FDA’s move fuel vaccine hesitancy? Sarah, David, Chris and Jonah give us the scoop. Today, our hosts also chat about
For your security, we need to re-authenticate you.
Click the link we sent to , or click here to log in.